You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Spielmeyer-Vogt-Sjögren-Batten Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuronal Ceroid Lipofuscinosis, Batten Disease, CLN1 Disease Trial in Hamburg (Natural History)

Recruiting
  • Neuronal Ceroid Lipofuscinosis
  • +14 more
  • Natural History
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Oct 22, 2021

Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

Recruiting
  • Rare Disorders
  • +309 more
    • Sioux Falls, South Dakota
    • +1 more
    Jun 20, 2022

    Neuronal Ceroid Lipofuscinosis Type 2 Trial in London (RGX-381)

    Not yet recruiting
    • Neuronal Ceroid Lipofuscinosis Type 2
    • RGX-381
    • London, United Kingdom
      Greater Ormond Street Hospital
    Mar 17, 2023

    Natural History Study of Batten Disease

    Terminated
    • Batten Disease
    • +2 more
      • Rochester, New York
        University of Rochester Medical Center
      Apr 1, 2022

      Mycophenolate Mofetil Combined With Glucocorticoid Therapy in

      Recruiting
      • Vogt-Koyanagi-Harada Disease
      • Mycophenolate Mofetil
      • Mycophenolate Mofetil
      • Tianjin, Tianjin, China
        xiaomin Zhang
      Nov 25, 2022

      A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

      Recruiting
      • Vogt-Koyanagi-Harada Disease
      • Adalimumab
      • Tianjin, Tianjin, China
        Tianjin Medical University Eye Hospital
      Oct 19, 2022

      Neuronal Ceroid Lipofuscinosis CLN5 Trial in Rochester (NGN-101)

      Recruiting
      • Neuronal Ceroid Lipofuscinosis CLN5
      • NGN-101
      • Rochester, New York
      • +1 more
      Jan 19, 2023

      Sjogren's Syndrome Trial in Reims (Evaluation of olfactory function, Evaluation of taste function, Evaluation of (intra-nasal

      Not yet recruiting
      • Sjogren's Syndrome
      • Evaluation of olfactory function
      • +2 more
      • Reims, France
        Université de Reims Champagne-Ardenne
      May 24, 2022

      Intestinal Microbiota in Gougerot-Sjögren Syndrome According to

      Recruiting
      • Sjogren's Syndrome
      • Biomarker detection
      • Nîmes, France
        CHU de Nimes
      May 24, 2022

      Sjögren and Gynecologic Considerations

      Completed
      • Primary Sjögren Syndrome
      • +3 more
      • Visual analogue scale (VAS) for dyspareunia
      • +3 more
      • Ankara, Turkey
        Ankara City Hospital
      Jan 3, 2023

      CLN3, Batten Disease Trial in Columbus (AT-GTX-502)

      Active, not recruiting
      • CLN3
      • Batten Disease
      • AT-GTX-502
      • Columbus, Ohio
        Nationwide Children's Hospital
      Jul 18, 2022

      Uveitis With Biologic Drugs in Resistant Cases

      Not yet recruiting
      • Uveitis
      • Biologic drugs
      • (no location specified)
      Apr 21, 2022

      Primary Sjögren Syndrome Patients

      Active, not recruiting
      • Sjogren's Syndrome
      • Parallel Assignment
      • São Paulo, Sao Paulo, Brazil
      • +1 more
      Nov 7, 2022

      CLN6 Batten Disease Subjects Following Gene Transfer

      Active, not recruiting
      • CLN6
      • Batten Disease
      • AT-GTX-501
      • Columbus, Ohio
        Nationwide Children's Hosptial
      Dec 17, 2021

      Anti-Argonaute Antibodies for Diagnosis of Sensory

      Completed
      • Autoimmune Diseases
      • Diagnosis of sensitive neuronopathy - phase 1
      • +4 more
      • Saint-Étienne, France
        CHU Saint-Etienne
      Jul 27, 2023

      Vogt Koyanagi Harada Disease Trial in São Paulo (Early high-dose corticosteroid and immunosuppressive therapy)

      Recruiting
      • Vogt Koyanagi Harada Disease
      • Early high-dose corticosteroid and immunosuppressive therapy
      • São Paulo, SP, Brazil
        Hospital das Clinicas HCFMUSP, Faculdade de Medicina Universidad
      Jan 4, 2022

      Corticosteroid Combining Noncorticosteroid Systemic

      Recruiting
      • Vogt Koyanagi Harada Disease (VKH)
      • noncorticosteroid systemic immunomodulatory therapy (NCSIT)
      • Guangzhou, Guangdong, China
        Zhongshan Ophthalmic Center
      Nov 3, 2021

      Systemic Lupus Erythematosus Trial in Changchun (IL-2)

      Completed
      • Systemic Lupus Erythematosus
      • Changchun, Changchun/Jilin, China
        Sirui Yang
      Aug 16, 2022

      Sjögren, Sjögren Syndrome Trial in Antalya (Pelvic floor exercises)

      Completed
      • Sjögren
      • Sjögren Syndrome
      • Pelvic floor exercises
      • Antalya, Turkey
        Antalya Training and Research Hospital
      Oct 11, 2022

      Late Infantile Variant CLN5 And CLN7 Disease

      Recruiting
      • Ceroid Lipofuscinosis, Neuronal 5
      • Ceroid Lipofuscinosis, Neuronal 7
        • Rochester, New York
          University of Rochester Medical Center
        Mar 1, 2022

        Nasal Obstruction, Septal Defect, Allergic Rhinitis Trial in Poplar Bluff, New York, Staten Island (Batten batten graft,

        Recruiting
        • Nasal Obstruction
        • +4 more
        • Batten batten graft
        • +2 more
        • Poplar Bluff, Missouri
        • +2 more
        Mar 11, 2022

        Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)

        Completed
        • Choroidal Neovascularization
        • Sao Paulo, Brazil
          Hospital das Clínicas- University of Sao Paulo
        Jan 4, 2022

        CLN7 Trial in Dallas (AAV9/CLN7)

        Recruiting
        • CLN7
        • AAV9/CLN7
        • Dallas, Texas
          Children' Health
        May 16, 2022

        Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety

        Completed
        • Sjogren's Syndrome
        • +5 more
        • FACT-F questionnaire
        • +6 more
        • Yıldırım, Bursa, Turkey
          Koray Ayar
        Nov 29, 2021

        Sjögren-Larsson Syndrome Trial in Omaha, Hershey, Fairfax (Active topical NS2 1% dermatologic cream, Vehicle 0.0% NS2

        Completed
        Has Results
        • Sjögren-Larsson Syndrome
        • Active topical NS2 1% dermatologic cream
        • Vehicle placebo 0.0% NS2 dermatologic cream
        • Omaha, Nebraska
        • +2 more
        Nov 16, 2022